Biotech

All Articles

Zephyrm finds Hong Kong IPO to fund period 3 tissue treatment tests

.Zephyrm Bioscience is actually gusting towards the Hong Kong stock market, submission (PDF) for an ...

Frazier Lifestyle Sciences gets $630M for small, mid-cap biotechs

.Frazier Lifespan Sciences has actually sourced a better $630 thousand for its own fund paid attenti...

GigaGen gathers up to $135M BARDA bucks to beat botulism

.Antibody enthusiast GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its technolog...

GPCR agency Septerna apply for IPO on stamina of preclinical information

.Septerna is about to discover exactly how a biotech without "any type of significant medical inform...

Kurma closes initially $154M loot for biggest biotech fund yet

.European VC organization Kurma Allies has introduced its own latest biotech fund, along with 140 mi...

Prothena markets one officer while one more places-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of substantial leadership hirings, firings and a...

Editas exploit Vertex Cas9 licensing civil rights for $57M

.Against the backdrop of a Cas9 license struggle that refuses to pass away, Editas Medication is mon...

Ultragenyx changes gene therapy dosing to call up efficiency

.A minority of patients taking Ultragenyx Drug's Wilson disease genetics therapy UX701 have gone ove...

Biopharma layoff price maintains in Q3: Strong Biotech evaluation

.As summertime warmth looks to cool down winds, wishes that this year would take extensive field all...

J &amp J drops phase 2 dengue prospect in newest shift from injections

.Johnson &amp Johnson's deprioritization of its own transmittable ailment pipeline has actually stat...